05 mesotelioma pleural maligno y timoma
DESCRIPTION
Autor/a Dra. Pilar Lianes V Jornada de Revisión del Congreso Mundial de Cáncer de Pulmón. ARCO MEDITERRANEO. Valencia 8-Nov-2013TRANSCRIPT
![Page 1: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/1.jpg)
![Page 2: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/2.jpg)
Diagnostics Problems
![Page 3: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/3.jpg)
Thymoma and Thymic Carcinoma:
Differences
Stages at presentation
Paraneoplastic syndromes in thymic carcinoma rarely
IHC differences:
EGFR more common in thymoma
C-kit more common in thymic carcinoma
Poorer prognosis of thymic carcinoma
![Page 4: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/4.jpg)
![Page 5: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/5.jpg)
![Page 6: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/6.jpg)
![Page 7: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/7.jpg)
![Page 8: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/8.jpg)
![Page 9: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/9.jpg)
![Page 10: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/10.jpg)
![Page 11: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/11.jpg)
![Page 12: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/12.jpg)
‹›
![Page 13: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/13.jpg)
![Page 14: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/14.jpg)
![Page 15: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/15.jpg)
![Page 16: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/16.jpg)
![Page 17: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/17.jpg)
![Page 18: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/18.jpg)
![Page 19: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/19.jpg)
![Page 20: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/20.jpg)
![Page 21: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/21.jpg)
![Page 22: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/22.jpg)
![Page 23: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/23.jpg)
Summary Thymic
Tumors Thymoma and Thymic Carcinoma are unique entities
Both are sensitive to broad range of chemotherapeutic agents
Anthracycline regimens associated with higher response rates in Thymoma
In Stage III Disease, radiation improves PFS but not OS
We need to better identify the “targets” for targeted therapy
Always consider multidisciplinary aproach
![Page 24: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/24.jpg)
![Page 25: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/25.jpg)
![Page 26: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/26.jpg)
![Page 27: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/27.jpg)
![Page 28: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/28.jpg)
![Page 29: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/29.jpg)
![Page 30: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/30.jpg)
![Page 31: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/31.jpg)
![Page 32: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/32.jpg)
![Page 33: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/33.jpg)
![Page 34: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/34.jpg)
![Page 35: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/35.jpg)
![Page 36: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/36.jpg)
![Page 37: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/37.jpg)
![Page 38: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/38.jpg)
![Page 39: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/39.jpg)
![Page 40: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/40.jpg)
![Page 41: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/41.jpg)
![Page 42: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/42.jpg)
![Page 43: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/43.jpg)
![Page 44: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/44.jpg)
The present study indicated that
appropriately selected patients
who underwent radical P/D had
lower perioperative morbidity
and mortality with similar, if not
superior, long-term survival
compared to EPP.
![Page 45: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/45.jpg)
![Page 46: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/46.jpg)
![Page 47: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/47.jpg)
![Page 48: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/48.jpg)
![Page 49: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/49.jpg)
![Page 50: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/50.jpg)
![Page 51: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/51.jpg)
![Page 52: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/52.jpg)
![Page 53: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/53.jpg)
![Page 54: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/54.jpg)
![Page 55: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/55.jpg)
QUÉ HEMOS APRENDIDO EN EL
MUNDIAL 2013 de Mesoteliomas
Que existe un grupo de trabajo internacional muy activo interesado en su diagnóstico y tratamiento (IMIG)
Que las sesiones han sido muy ricas en contenido y discusión
Que la prevención epidemiológica aún es posible
Que tenemos esperanza en drogas prometedoras
Que los pacientes se merecen nuestro esfuerzo multidisciplinar
![Page 56: 05 Mesotelioma pleural maligno y timoma](https://reader033.vdocuments.site/reader033/viewer/2022050905/549c89a5ac7959c92a8b4777/html5/thumbnails/56.jpg)